Article
Prevalence and human papillomavirus (HPV) genotype distribution in Suzhou, China.
Human vaccines & immunotherapeutics - 1 Aug 2023
Wang Tianyu, Luan Lin, Deng Jingjing, Liu Na, Wu Qianlan, Gong Tian, Zhu Jie, Zhang Zhuoyu, Zhang Jun
Abstract excerpt
Persistent infection with high-risk human papillomavirus (HR-HPV) is a known pathogenic factor of cervical cancer. To develop scientific guidance for cervical cancer screening and HPV vaccination, we analyzed HPV genotypes in Suzhou City, China. This study utilized data from the cervical cancer screening project in Suzhou from 2016 to 2021. A total of 444,471 female residents who voluntarily underwent HPV testing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
